A detailed history of Asset Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Asset Management Corp holds 21,776 shares of ABBV stock, worth $4.44 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
21,776
Previous 22,278 2.25%
Holding current value
$4.44 Million
Previous $3.6 Million 3.66%
% of portfolio
2.38%
Previous 2.88%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $72,594 - $83,603
-502 Reduced 2.25%
21,776 $3.47 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $203,454 - $243,994
-1,471 Reduced 6.19%
22,278 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $4,026 - $4,617
-30 Reduced 0.13%
23,749 $3.19 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $10,871 - $13,821
79 Added 0.33%
23,779 $3.64 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $121,553 - $150,813
-921 Reduced 3.74%
23,700 $3.84 Million
Q4 2021

Jan 25, 2022

SELL
$107.43 - $135.93 $37,385 - $47,303
-348 Reduced 1.39%
24,621 $3.33 Million
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $505,400 - $573,705
4,750 Added 23.49%
24,969 $2.69 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $35,245 - $39,265
-335 Reduced 1.63%
20,219 $2.28 Million
Q1 2021

May 04, 2021

SELL
$102.3 - $112.62 $53,605 - $59,012
-524 Reduced 2.49%
20,554 $2.22 Million
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $150,677 - $203,430
-1,872 Reduced 8.16%
21,078 $2.33 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $9,536 - $11,192
-111 Reduced 0.48%
22,950 $2.01 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $40,353 - $53,999
-550 Reduced 2.33%
23,061 $2.26 Million
Q1 2020

Apr 14, 2020

SELL
$64.5 - $97.79 $46,440 - $70,408
-720 Reduced 2.96%
23,611 $1.8 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $1.75 Million - $2.2 Million
24,331 New
24,331 $2.15 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Asset Management Corp Portfolio

Follow Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Corp with notifications on news.